Send the following on WhatsApp
Continue to ChatPotential increased risk of death and serious adverse effects with cancer medicine Copiktra (duvelisib): USFDA Drug safety communication https://publicsafetyandvigilance.com/2022/07/potential-increased-risk-of-death-and-serious-adverse-effects-with-cancer-medicine-copiktra-duvelisib-usfda-drug-safety-communication/